Title : EGFR and HER-2 antagonists in breast cancer.

Pub. Date : 2007 May-Jun

PMID : 17593621






1 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Recent results from trials of the dual HER-2 and EGFR tyrosine kinase inhibitor, lapatinib, also show very promising results in HER-2-positive breast cancer. Lapatinib epidermal growth factor receptor Homo sapiens